Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation

Details for Australian Patent Application No. 2010201070 (hide)

International Classifications

Event Publications

8 April 2010 Complete Application Filed

15 April 2010 Application Open to Public Inspection

Published as AU-A-2010201070

7 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

26 May 2011 Section 223 Application Received

Map Pharmaceuticals, Inc. An application to extend the time from 10 Sep 2010 to 10 May 2011 in which to pay a continuation fee has been filed . Address for service in Australia - EF WELLINGTON & CO 312 St Kilda Road Southbank MELBOURNE VIC 3006 Extensions of Time, Section 223

14 July 2011 Section 223 Application Allowed

Map Pharmaceuticals, Inc. The time in which to pay a continuation fee has been extended to 10 May 2011. Address for service in Australia - EF WELLINGTON & CO 312 St Kilda Road Southbank MELBOURNE VIC 3006 Extensions of Time, Section 223

24 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.